TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL ANTIMALARIAL DRUGS MARKET, BY DRUG CLASS
6.1. Overview
6.2. Aryl Aminoalcohol Compounds
6.3. Antifolate Compounds
6.4. Artemisinin Compounds
6.5. Others
7. GLOBAL ANTIMALARIAL DRUGS MARKET, BY MALARIA TYPE
7.1. Overview
7.2. Plasmodium Falciparum
7.3. Plasmodium Vivax
7.4. Plasmodium Malariae
7.5. Plasmodium Ovale
8. GLOBAL ANTIMALARIAL DRUGS MARKET, BY MECHANISM OF ACTION
8.1. Overview
8.2. Treatment for Malaria
8.3. Prevention from Malaria
9. GLOBAL ANTIMALARIAL DRUGS MARKET, BY REGION
9.1. Overview
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. UK
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Middle East
9.4.2. Africa
9.4.3. Latin America
10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Antimalarial Drugs Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Antimalarial Drugs Market,
10.7. Key Developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2023
10.8.2. Major Players R&D Expenditure. 2023
11. COMPANY PROFILES
11.1. NOVARTIS AG
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Mylan N.V.
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Pfizer Inc.
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Sanofi
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. GlaxoSmithKline plc
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Cipla Inc.
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Ipca Laboratories Ltd
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. HOFFMANN-LA ROCHE LTD
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Sun Pharmaceutical Industries Ltd.
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL ANTIMALARIAL DRUGS MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL ANTIMALARIAL DRUGS MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL ANTIMALARIAL DRUGS MARKET, BY DRUG CLASS, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL ANTIMALARIAL DRUGS MARKET, BY MALARIA TYPE, 2019-2032 (USD BILLION)
TABLE 5 GLOBAL ANTIMALARIAL DRUGS MARKET, BY MECHANISM OF ACTION, 2019-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: ANTIMALARIAL DRUGS MARKET, BY DRUG CLASS, 2019-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: ANTIMALARIAL DRUGS MARKET, BY MALARIA TYPE, 2019-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: ANTIMALARIAL DRUGS MARKET, BY MECHANISM OF ACTION, 2019-2032 (USD BILLION)
TABLE 9 US: ANTIMALARIAL DRUGS MARKET, BY DRUG CLASS, 2019-2032 (USD BILLION)
TABLE 10 US: ANTIMALARIAL DRUGS MARKET, BY MALARIA TYPE, 2019-2032 (USD BILLION)
TABLE 11 US: ANTIMALARIAL DRUGS MARKET, BY MECHANISM OF ACTION, 2019-2032 (USD BILLION)
TABLE 12 CANADA: ANTIMALARIAL DRUGS MARKET, BY DRUG CLASS, 2019-2032 (USD BILLION)
TABLE 13 CANADA: ANTIMALARIAL DRUGS MARKET, BY MALARIA TYPE, 2019-2032 (USD BILLION)
TABLE 14 CANADA: ANTIMALARIAL DRUGS MARKET, BY MECHANISM OF ACTION, 2019-2032 (USD BILLION)
TABLE 1 EUROPE: ANTIMALARIAL DRUGS MARKET, BY DRUG CLASS, 2019-2032 (USD BILLION)
TABLE 2 EUROPE: ANTIMALARIAL DRUGS MARKET, BY MALARIA TYPE, 2019-2032 (USD BILLION)
TABLE 3 EUROPE: ANTIMALARIAL DRUGS MARKET, BY MECHANISM OF ACTION, 2019-2032 (USD BILLION)
TABLE 4 GERMANY: ANTIMALARIAL DRUGS MARKET, BY DRUG CLASS, 2019-2032 (USD BILLION)
TABLE 5 GERMANY: ANTIMALARIAL DRUGS MARKET, BY MALARIA TYPE, 2019-2032 (USD BILLION)
TABLE 6 GERMANY: ANTIMALARIAL DRUGS MARKET, BY MECHANISM OF ACTION, 2019-2032 (USD BILLION)
TABLE 7 FRANCE: ANTIMALARIAL DRUGS MARKET, BY DRUG CLASS, 2019-2032 (USD BILLION)
TABLE 8 FRANCE: ANTIMALARIAL DRUGS MARKET, BY MALARIA TYPE, 2019-2032 (USD BILLION)
TABLE 9 FRANCE: ANTIMALARIAL DRUGS MARKET, BY MECHANISM OF ACTION, 2019-2032 (USD BILLION)
TABLE 10 ITALY: ANTIMALARIAL DRUGS MARKET, BY DRUG CLASS, 2019-2032 (USD BILLION)
TABLE 11 ITALY: ANTIMALARIAL DRUGS MARKET, BY MALARIA TYPE, 2019-2032 (USD BILLION)
TABLE 12 ITALY: ANTIMALARIAL DRUGS MARKET, BY MECHANISM OF ACTION, 2019-2032 (USD BILLION)
TABLE 13 SPAIN: ANTIMALARIAL DRUGS MARKET, BY DRUG CLASS, 2019-2032 (USD BILLION)
TABLE 14 SPAIN: ANTIMALARIAL DRUGS MARKET, BY MALARIA TYPE, 2019-2032 (USD BILLION)
TABLE 15 SPAIN: ANTIMALARIAL DRUGS MARKET, BY MECHANISM OF ACTION, 2019-2032 (USD BILLION)
TABLE 16 UK: ANTIMALARIAL DRUGS MARKET, BY DRUG CLASS, 2019-2032 (USD BILLION)
TABLE 17 UK: ANTIMALARIAL DRUGS MARKET, BY MALARIA TYPE, 2019-2032 (USD BILLION)
TABLE 18 UK: ANTIMALARIAL DRUGS MARKET, BY MECHANISM OF ACTION, 2019-2032 (USD BILLION)
TABLE 19 REST OF EUROPE: ANTIMALARIAL DRUGS MARKET, BY DRUG CLASS, 2019-2032 (USD BILLION)
TABLE 20 REST OF EUROPE: ANTIMALARIAL DRUGS MARKET, BY MALARIA TYPE, 2019-2032 (USD BILLION)
TABLE 21 REST OF EUROPE: ANTIMALARIAL DRUGS MARKET, BY MECHANISM OF ACTION, 2019-2032 (USD BILLION)
TABLE 22 ASIA-PACIFIC: ANTIMALARIAL DRUGS MARKET, BY DRUG CLASS, 2019-2032 (USD BILLION)
TABLE 23 ASIA-PACIFIC: ANTIMALARIAL DRUGS MARKET, BY MALARIA TYPE, 2019-2032 (USD BILLION)
TABLE 24 ASIA-PACIFIC: ANTIMALARIAL DRUGS MARKET, BY MECHANISM OF ACTION, 2019-2032 (USD BILLION)
TABLE 25 JAPAN: ANTIMALARIAL DRUGS MARKET, BY DRUG CLASS, 2019-2032 (USD BILLION)
TABLE 26 JAPAN: ANTIMALARIAL DRUGS MARKET, BY MALARIA TYPE, 2019-2032 (USD BILLION)
TABLE 27 JAPAN: ANTIMALARIAL DRUGS MARKET, BY MECHANISM OF ACTION, 2019-2032 (USD BILLION)
TABLE 28 CHINA: ANTIMALARIAL DRUGS MARKET, BY DRUG CLASS, 2019-2032 (USD BILLION)
TABLE 29 CHINA: ANTIMALARIAL DRUGS MARKET, BY MALARIA TYPE, 2019-2032 (USD BILLION)
TABLE 30 CHINA: ANTIMALARIAL DRUGS MARKET, BY MECHANISM OF ACTION, 2019-2032 (USD BILLION)
TABLE 31 INDIA: ANTIMALARIAL DRUGS MARKET, BY DRUG CLASS, 2019-2032 (USD BILLION)
TABLE 32 INDIA: ANTIMALARIAL DRUGS MARKET, BY MALARIA TYPE, 2019-2032 (USD BILLION)
TABLE 33 INDIA: ANTIMALARIAL DRUGS MARKET, BY MECHANISM OF ACTION, 2019-2032 (USD BILLION)
TABLE 34 AUSTRALIA: ANTIMALARIAL DRUGS MARKET, BY DRUG CLASS, 2019-2032 (USD BILLION)
TABLE 35 AUSTRALIA: ANTIMALARIAL DRUGS MARKET, BY MALARIA TYPE, 2019-2032 (USD BILLION)
TABLE 36 AUSTRALIA: ANTIMALARIAL DRUGS MARKET, BY MECHANISM OF ACTION, 2019-2032 (USD BILLION)
TABLE 37 SOUTH KOREA: ANTIMALARIAL DRUGS MARKET, BY DRUG CLASS, 2019-2032 (USD BILLION)
TABLE 38 SOUTH KOREA: ANTIMALARIAL DRUGS MARKET, BY MALARIA TYPE, 2019-2032 (USD BILLION)
TABLE 39 SOUTH KOREA: ANTIMALARIAL DRUGS MARKET, BY MECHANISM OF ACTION, 2019-2032 (USD BILLION)
TABLE 40 REST OF ASIA-PACIFIC: ANTIMALARIAL DRUGS MARKET, BY DRUG CLASS, 2019-2032 (USD BILLION)
TABLE 41 REST OF ASIA-PACIFIC: ANTIMALARIAL DRUGS MARKET, BY MALARIA TYPE, 2019-2032 (USD BILLION)
TABLE 42 REST OF ASIA-PACIFIC: ANTIMALARIAL DRUGS MARKET, BY MECHANISM OF ACTION, 2019-2032 (USD BILLION)
TABLE 43 REST OF THE WORLD: ANTIMALARIAL DRUGS MARKET, BY DRUG CLASS, 2019-2032 (USD BILLION)
TABLE 44 REST OF THE WORLD: ANTIMALARIAL DRUGS MARKET, BY MALARIA TYPE, 2019-2032 (USD BILLION)
TABLE 45 REST OF THE WORLD: ANTIMALARIAL DRUGS MARKET, BY MECHANISM OF ACTION, 2019-2032 (USD BILLION)
TABLE 46 MIDDLE EAST: ANTIMALARIAL DRUGS MARKET, BY DRUG CLASS, 2019-2032 (USD BILLION)
TABLE 47 MIDDLE EAST: ANTIMALARIAL DRUGS MARKET, BY MALARIA TYPE, 2019-2032 (USD BILLION)
TABLE 48 MIDDLE EAST: ANTIMALARIAL DRUGS MARKET, BY MECHANISM OF ACTION, 2019-2032 (USD BILLION)
TABLE 49 AFRICA: ANTIMALARIAL DRUGS MARKET, BY DRUG CLASS, 2019-2032 (USD BILLION)
TABLE 50 AFRICA: ANTIMALARIAL DRUGS MARKET, BY MALARIA TYPE, 2019-2032 (USD BILLION)
TABLE 51 AFRICA: ANTIMALARIAL DRUGS MARKET, BY MECHANISM OF ACTION, 2019-2032 (USD BILLION)
TABLE 52 LATIN AMERICA: ANTIMALARIAL DRUGS MARKET, BY DRUG CLASS, 2019-2032 (USD BILLION)
TABLE 53 LATIN AMERICA: ANTIMALARIAL DRUGS MARKET, BY MALARIA TYPE, 2019-2032 (USD BILLION)
TABLE 54 LATIN AMERICA: ANTIMALARIAL DRUGS MARKET, BY MECHANISM OF ACTION, 2019-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ANTIMALARIAL DRUGS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ANTIMALARIAL DRUGS MARKET
FIGURE 4 GLOBAL ANTIMALARIAL DRUGS MARKET, SHARE (%), BY DRUG CLASS, 2023
FIGURE 5 GLOBAL ANTIMALARIAL DRUGS MARKET, SHARE (%), BY MALARIA TYPE, 2023
FIGURE 6 GLOBAL ANTIMALARIAL DRUGS MARKET, SHARE (%), BY MECHANISM OF ACTION, 2023
FIGURE 7 GLOBAL ANTIMALARIAL DRUGS MARKET, SHARE (%), BY REGION, 2023
FIGURE 8 NORTH AMERICA: ANTIMALARIAL DRUGS MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 EUROPE: ANTIMALARIAL DRUGS MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 ASIA-PACIFIC: ANTIMALARIAL DRUGS MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 REST OF THE WORLD: ANTIMALARIAL DRUGS MARKET, SHARE (%), BY REGION, 2023
FIGURE 12 GLOBAL ANTIMALARIAL DRUGS MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 13 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 NOVARTIS AG: SWOT ANALYSIS
FIGURE 15 MYLAN N.V.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 MYLAN N.V.: SWOT ANALYSIS
FIGURE 17 PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 PFIZER INC.: SWOT ANALYSIS
FIGURE 19 SANOFI: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 SANOFI: SWOT ANALYSIS
FIGURE 21 GLAXOSMITHKLINE PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 GLAXOSMITHKLINE PLC: SWOT ANALYSIS
FIGURE 23 CIPLA INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 CIPLA INC.: SWOT ANALYSIS
FIGURE 25 IPCA LABORATORIES LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 IPCA LABORATORIES LTD: SWOT ANALYSIS
FIGURE 27 HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS
FIGURE 29 SUN PHARMACEUTICAL INDUSTRIES LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 SUN PHARMACEUTICAL INDUSTRIES LTD.: SWOT ANALYSIS
